Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

124.75
+0.62000.50%
Post-market: 124.750.00000.00%19:44 EDT
Volume:2.29M
Turnover:283.97M
Market Cap:13.95B
PE:59.57
High:124.97
Open:124.48
Low:121.51
Close:124.13
52wk High:124.97
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:1.78
T/O Rate:2.24%
Dividend:0.28
Dividend Rate:0.22%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:1.93
PE(LYR):60.30

Loading ...

Revvity Inc. Stock Advances 3.9%, Outperforms Peers

Dow Jones
·
Aug 21

Movement Alert|REVVITY INC Rises 5.16% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Sector-Wide Strength

Market Focus
·
Aug 20

Revvity (RVTY) Stock Looks Reasonable On Cash Flow Yet Rich On Earnings

Simply Wall St.
·
Aug 14

Revvity 10-Q Filing Delayed at SEC, B3 Depositary Says

Reuters
·
Aug 12

Revvity to Present at Wells Fargo Annual Healthcare Investor Conference

Reuters
·
Aug 11

Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 11

Revvity Releases Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 06

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Revvity is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Aug 05

Revvity price target raised to $126 from $125 at Evercore ISI

TIPRANKS
·
Aug 05

Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Revvity, Inc. : Bernstein Raises Target Price to $120 from $115

THOMSON REUTERS
·
Aug 05

Revvity, Inc. : JP Morgan Raises Target Price to $110 from $90

THOMSON REUTERS
·
Aug 05

Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 05

Stock Track | REVVITY INC Plummets 5.01% Intraday as Life Sciences Unit Weakness Overshadows Q2 Earnings Beat

Stock Track
·
Aug 04

Revvity Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Revvity Announces Q3 2026 Distribution of R$ 0.01 Per Unit, Payable Nov. 19

Reuters
·
Aug 04

Revvity Exec Says Co is Seeing Improving Demand from Biotech Customers, Aided by a Growing Number of AI-Related Orders - Conf Call

THOMSON REUTERS
·
Aug 04

Revvity Exec Says Decline in Life Sciences Unit was Driven by About 20% Decline in Co's Signal Software Business Due to Contract Timing

THOMSON REUTERS
·
Aug 04

Revvity Exec Says Co is NOW "More Optimistic" for Second Half of the Year Given the Diagnostic Trends

THOMSON REUTERS
·
Aug 04